Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK3 | P52333 | 20/20 | 0.69 |
| ▸ | TYK2 | P29597 | 19/20 | 0.69 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.69 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.69 |
| ▸ | JAK1 | P23458 | 14/20 | 0.68 |
| ▸ | JAK2 | O60674 | 13/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30569770 | 1.00 | JAK3 (0.69) | JAK3TYK2P2RX3P2RX2JAK1 | |
| SCHEMBL18271836 | 1.00 | JAK3 (0.69) | JAK3TYK2P2RX3P2RX2JAK1 | |
| Hydrochloric Acid SCHEMBL30569787 | 0.99 | JAK3 (0.68) | JAK3TYK2P2RX3P2RX2JAK1 | |
| SCHEMBL29707886 | 0.96 | TYK2 (0.70) | JAK3TYK2P2RX3P2RX2JAK1 | |
| SCHEMBL21229857 | 0.96 | TYK2 (0.70) | JAK3TYK2P2RX3P2RX2JAK1 | |
| SCHEMBL24594223 | 0.96 | TYK2 (0.70) | JAK3TYK2P2RX3P2RX2JAK1 | |
| SCHEMBL18269690 | 0.96 | TYK2 (0.70) | JAK3TYK2P2RX3P2RX2JAK1 | |
| SCHEMBL24337003 | 0.96 | TYK2 (0.70) | JAK3TYK2P2RX3P2RX2JAK1 | |
| SCHEMBL22055026 | 0.88 | TYK2 (0.63) | JAK3TYK2P2RX3P2RX2JAK1 | |
| SCHEMBL21676342 | 0.87 | TYK2 (0.69) | JAK3TYK2P2RX3P2RX2JAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3303348-B1 | NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS | THERAVANCE BIOPHARMA R&D IP LLC (US) | 2019-08-07 | — | — | EP | disclosed |